Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Total Current Liabilities (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Total Current Liabilities for 6 consecutive years, with $18.5 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 5.25% to $18.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.5 million through Dec 2025, up 5.25% year-over-year, with the annual reading at $18.5 million for FY2025, 5.25% up from the prior year.
  • Total Current Liabilities hit $18.5 million in Q4 2025 for Rapid Micro Biosystems, up from $16.5 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $19.0 million in Q4 2022 to a low of $12.8 million in Q2 2022.
  • Historically, Total Current Liabilities has averaged $16.2 million across 5 years, with a median of $16.0 million in 2021.
  • Biggest five-year swings in Total Current Liabilities: increased 16.86% in 2021 and later dropped 20.34% in 2022.
  • Year by year, Total Current Liabilities stood at $18.2 million in 2021, then grew by 4.87% to $19.0 million in 2022, then decreased by 0.34% to $19.0 million in 2023, then fell by 7.48% to $17.6 million in 2024, then increased by 5.25% to $18.5 million in 2025.
  • Business Quant data shows Total Current Liabilities for RPID at $18.5 million in Q4 2025, $16.5 million in Q3 2025, and $16.4 million in Q2 2025.